Annual Drug Patent Expirations for ORLADEYO
Orladeyo is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has sixty-nine patent family members in thirty-four countries.
The generic ingredient in ORLADEYO is berotralstat hydrochloride. One supplier is listed for this compound. Additional details are available on the berotralstat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
